CPRX - Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference | Benzinga
CORAL GABLES, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (NASDAQ:CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases, today announced that Richard J. Daly, CEO of Catalyst, along with other members of Catalyst's management team, will participate at the upcoming Barclays 26th Annual Global Healthcare Conference being held in Miami on March 12-14, 2024.
Participation Details:
Date: Tuesday, March 12, 2024
Format: Catalyst's management will host 1x1 meetings and a fireside discussion at 1:35 pm ET.
A live webcast of the fireside will be available on the Company's website, and a replay will be accessible for at least 14 days.
About Catalyst Pharmaceuticals, Inc.
With exceptional patient focus, Catalyst is committed to developing and commercializing innovative first-in-class medicines that address rare and difficult-to-treat diseases. Catalyst's flagship U.S. commercial product is FIRDAPSE® (amifampridine) ...